Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma

BACKGROUND: Outcomes of patients with metastatic melanoma discontinuing BRAF‐targeted therapy for cumulative toxicity after sustained response are unknown. MATERIALS AND METHODS: This retrospective case series analysis conducted at a single Cancer Center in Italy included patients with BRAF mutated...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Guardo, Lorenza, Randon, Giovanni, Corti, Francesca, Vallacchi, Viviana, Raimondi, Alessandra, Fucà, Giovanni, Bini, Marta, Maurichi, Andrea, Patuzzo, Roberto, Gallino, Gianfrancesco, Mattavelli, Ilaria, Ruggeri, Roberta, Angi, Martina, Cossa, Mara, Valeri, Barbara, Cimminiello, Carolina, Santinami, Mario, Rivoltini, Licia, de Braud, Filippo, Rodolfo, Monica, Vecchio, Michele Del
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Melanoma and Cutaneous Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649022/
https://www.ncbi.nlm.nih.gov/pubmed/34355463
http://dx.doi.org/10.1002/onco.13926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649022/
https://www.ncbi.nlm.nih.gov/pubmed/34355463
http://dx.doi.org/10.1002/onco.13926

Ejemplares similares